Concentrations of Nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 1, 2007, Pages 173-179

  Avois, Lidia ^a   Mangin, Patrice ^a   Saugy, Martial ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Anabolic steroids; Doping; GC MS; Nandrolone; Ophthalmic solution; Urine

Indexed keywords

19 NORANDROSTERONE; 19 NORETIOCHOLANOLONE; DRUG METABOLITE; EYE DROPS; KERATYL; NANDROLONE; SODIUM SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; URINALYSIS; VOLUNTEER;

ADULT; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEAT; HUMANS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; NANDROLONE; OPHTHALMIC SOLUTIONS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; URINE;

EID: 34047263965     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.02.012     Document Type: Article

References (26)

1. Basaria S., Wahlstrom J.T., and Dobs A. J. Clin. Endocrinol. Metab. 86 (2001) 5108-5117
2. Dehennin L., Bonnaire Y., and Plou Ph. J. Chromatogr. B 721 (1999) 301-307
3. Le Bizec B., Monteau F., Gaudin I., and André F. J. Chromatogr. B 723 (1999) 157-172
4. Robinson N., Taroni F., Saugy M., Ayotte C., and Dvorak J. For. Sci. Int. 122 (2001) 130-135
5. Schmitt N., Flament M.M., Goubault C., Legros P., Grenier-Loustalot M.F., and Denjean A. Med. Sci. Sports Exerc. 34 (2002) 1436-1439
6. Baume N., Avois L., Sottas P.E., Dvorak J., Cauderay M., Mangin P., and Saugy M. Clin. J. Sport Med. 15 (2005) 158-166
7. Baume N., Mahler N., Kamber M., Mangin P., and Saugy M. Scan. J. Med. Sci. Sport 16 (2005) 41-48
8. www.wada-ama.org
9. Catlin D., Cowan D., Donike M., Fraisse D., Oftebro H., and Rendic S. Clin. Chim. Acta 207 (1992) S13-S26
10. Massé R., Ayotte C., and Dugal R. J. Chromatogr. 489 (1989) 23-50
11. Chung B., Choo H.Y., Kim T., Eom K., Kwon O., and Suh J. J. Anal. Toxicol. 14 (1990) 91-95
12. Schänzer W., and Donike M. Anal. Chim. Acta 275 (1993) 23-48
13. In: Geyer H., Mareck-Engelke U., Schänzer W., and Donike M. (Eds). Recent Advances in Doping Analysis 1 (1994), Sport and Buch Strauss, Cologne, Germany 97-103
14. Ayotte C., Goudreault D., and Charlebois A. J. Chromatogr. B 687 (1996) 3-25
15. Hubert L. Recent Advances in Doping Analysis 3 (1996), Sport and Buch Strauss, Cologne, Germany pp. 299-312
16. ICH: Harmonised Tripartite Guideline. Q2A: Text on Validation of Analytical Procedures, 1994.
17. ICH: Harmonised Tripartite Guideline. Q2B: Validation of Analytical Procedures: Methodology, 1996.
18. Eurolab EAL-P11. Validation of Test Methods: general principles and concepts, 1997.
19. Hartmann C., Smeyers-Verbeke J., Massart D.L., and McDowall R.D. J. Pharm. Biomed. Anal. 17 (1998) 193-218
20. FDA Draft Guidance for Industry. Analytical Procedures and Methods Validation, 2000.
21. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., and McGilveray I.J. Bioanalytical method validation-a revisit with a decade of progress. Workshop/conference report. Pharmaceut. Res. 17 (2000) 1551-1557
22. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., and Massart D.L. J. Pharm. Biomed. Anal. 24 (2001) 723-753
23. Dehennin L., Lafarge P., Dailly Ph., Bailloux D., and Lafarge J.-P. J. Chromatogr. B 687 (1996) 85-91
24. Tseng Y.L., Sun C.-Y., and Kuo F.-H. Steroids 71 (2006) 817-827
25. Kaur I.P., Garg A., Singla A.K., and Aggarwal D. Int. J. Pharm. 269 (2004) 1-14
26. Baume N., Avois L., Schweizer C., Cardis C., Dvorak J., Cauderay M., Mangin P., and Saugy M. Clin. Chem. 50 (2004) 355-364